| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689224 | European Urology | 2017 | 6 Pages |
Abstract
We used a large hospital-based database to evaluate which patients might benefit from local therapy when metastasized prostate cancer was present at diagnosis. Local therapy is associated with a survival benefit in men with less aggressive tumors and good general health.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Björn Löppenberg, Deepansh Dalela, Patrick Karabon, Akshay Sood, Jesse D. Sammon, Christian P. Meyer, Maxine Sun, Joachim Noldus, James O. Peabody, Quoc-Dien Trinh, Mani Menon, Firas Abdollah,